Web Stats Provided By Google Analytics

Monday, March 24, 2014

[Research Articles] Polyfunctional Fc-Effector Profiles Mediated by...

The human phase 2B RV144 ALVAC-HIV vCP1521/AIDSVAX B/E vaccine trial, held in Thailand, resulted in an estimated 31.2% efficacy against HIV infection.

http://ift.tt/1gZKidu
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)